Hematopoietic cell transplantation in chronic myeloid leukemia in the age of tyrosine kinase inhibitors.

Abstract

The development and widespread use of tyrosine kinase inhibitors (TKIs) has relegated the use of hematopoietic cell transplant (HCT), in most countries, to chronic myeloid leukemia (CML) patients who fail or are intolerant to TKIs. Its long-term cost effectiveness compared to TKIs, however, has maintained its use as front-line treatment in some areas… (More)

Topics

Cite this paper

@article{Copelan2015HematopoieticCT, title={Hematopoietic cell transplantation in chronic myeloid leukemia in the age of tyrosine kinase inhibitors.}, author={Edward A. Copelan and Michael Richard Grunwald and Nilanjan Ghosh and Dragos Plesca and Jigar Trivedi and Belinda R. Avalos}, journal={Discovery medicine}, year={2015}, volume={19 104}, pages={213-8} }